NEWS / BLOG
Gentronix News and Blog section gives you our latest company updates, comments on the field of toxicology and insights into our business, values and commitment to our clients.
LATEST NEWS
Gentronix Ltd appoints experienced CRO executive as its new non-executive Chairman
Following the retirement of previous Chairman, John Nicholson, at the end of 2019, the Gentronix Board of Directors welcomes Alan Morgan as non-executive Chairman. Alan joins the Gentr [...]
Gentronix Ltd set to double in size following Northern VCT investment
Gentronix Ltd, a contract research business based at Alderley Park, is planning to double in size following a £750,000 investment from the Northern Venture Capital Trust Funds (VCTs), [...]
Gentronix will be at Eurotox 2019
Gentronix is looking forward to meeting you at Eurotox 2019 in Helsinki in September (7th-11th). Attending will be our Managing Director, Matt Tate, and our skin sensitisation expert, [...]
BLOG
Detecting Mutagens Using In Vitro Assays: Part 3 – Aneugens
After our earlier consideration of studies aimed at detecting point mutations and clastogens in parts 1 and 2 of this series, we come onto the last broad class of mutagens – aneugens. [...]
Comparing the 24-well Ames to the Full plate Ames study with food contact materials
Recently Gentronix has been working with Nestle on investigating whether miniaturised forms of the Ames assay could have utility in the context of food contact materials, as in some ca [...]
Detecting Mutagens Using In Vitro Assays: Part 2 – Clastogens
In part one of this article on detecting mutagens, we looked at mutagenic substances that are able to cause point mutations and the tools that can be used to assess such hazards. In pa [...]
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Excellence; we strive to deliver the highest quality service using the most appropriate scientific tools.
Effectiveness; we aim to deliver high quality results when you need them.
Efficiency; we optimise our approach to deliver maximum data from minimum material.
Engagement; we engage scientifically to support study design through to data interpretation and management.
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Excellence; we strive to deliver the highest quality service using the most appropriate scientific tools.
Effectiveness; we aim to deliver high quality results when you need them.
Efficiency; we optimise our approach to deliver maximum data from minimum material.
Engagement; we engage scientifically to support study design through to data interpretation and management.
LATEST VACANCIES
At Gentronix, we have a passion for the science of toxicology. Building on our experience gained from the pharmaceutical, agrochemical and CRO industries, we are committed to engaging with our clients to deliver the highest quality to science to support their projects. If believe you have the toxicology knowledge and the interest to support us in delivering this commitment, we’re interested to learn more.
In vitro mammalian gene mutation Study Director
Job Reference: GTXHPRT2020 (please included in application email subject line) Opening Date – 10th January 2020 Closing Date – 10th February 2020 Gentronix is seeking an enthusiastic [...]
Scientist / Study Investigator
The Opportunity We are seeking an enthusiastic and highly motivated scientist to join our in vitro mammalian toxicology team. The team is growing and needs a committed and organised in [...]
Laboratory Technician
The Opportunity We are seeking an enthusiastic and highly motivated lab technician to join our growing team. We are seeking a committed and organised individual to provide technical s [...]
Predictive Toxicology, Expertly Delivered